NewsRoom Articles - Page 573 of 1390

TuesdaySep 01, 2020 10:00 am

Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT) Starts Presentation at The LD 500

Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT) is a leading provider of innovative network intelligence and security solutions that empower communications service providers and enterprises worldwide, bringing enhanced value to customers. Allot's solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services and more. With more than 20 years of proven success, Allot's solutions turn network, application, usage and security data into actionable intelligence, making customers' networks smarter and their users more secure. Allot's multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1,000 enterprises. Allot's industry-leading, network-based security…

TuesdaySep 01, 2020 9:40 am

U.S. Gold Corp. (NASDAQ: USAU) Starts Presentation at The LD 500

U.S. Gold Corp. (NASDAQ: USAU) is a publicly traded, U.S.-focused gold exploration company. U.S. Gold Corp. has a portfolio of exploration properties. Copper King is located in Southeast Wyoming and has a preliminary economic assessment (PEA) technical report, which was completed by Mine Development Associates. Keystone and Maggie Creek are exploration properties on the Cortez and Carlin Trends in Nevada. For more information, visit the company's website at www.usgoldcorp.gold About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates from…

TuesdaySep 01, 2020 9:40 am

Lineage Cell Therapeutics Inc. (NYSE American: LCTX) Starts Presentation at The LD 500

Lineage Cell Therapeutics Inc. (NYSE American: LCTX) is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage's clinical programs are in markets with billion-dollar opportunities and include three allogeneic ("off-the-shelf") product candidates: (i) OpRegen(R), a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in…

TuesdaySep 01, 2020 9:40 am

InfuSystems Holdings Inc. (NYSE American: INFU) Starts Presentation at The LD 500

InfuSystems Holdings Inc. (NYSE American: INFU) is a leading provider of infusion pumps and related durable medical equipment support services to hospitals, clinics and other alternate site health care providers. InfuSystem provides pole-mounted and ambulatory pumps and supplies, along with related clinical, biomedical and billing services, to practices and patients nationwide. Headquartered in Rochester Hills, Michigan, the company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada. For more information, visit the company's website at www.infusystem.com About The LD 500 The LD 500 is the most ambitious project in LD…

TuesdaySep 01, 2020 9:40 am

Conversion Labs Inc. (OTCQB: CVLB) Starts Presentation at The LD 500

Conversion Labs Inc. (OTCQB: CVLB) is a telemedicine company with a portfolio of online direct-to-consumer brands. The company's brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. Conversion Labs is applying its direct-response marketing expertise to health care and providing a convenient, cost-effective and smarter way for consumers to access high-quality OTC products and prescription medications. For more information, visit the company's website at www.conversionlabs.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's…

TuesdaySep 01, 2020 9:20 am

Esports Entertainment Group Inc. (NASDAQ: GMBL) Starts Presentation at The LD 500

Esports Entertainment Group Inc. (NASDAQ: GMBL) is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange-style wagering on esports events through a licensed, regulated and secure platform to the global esports audience. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and video game industries, as well as esports. The…

TuesdaySep 01, 2020 9:20 am

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) Starts Presentation at The LD 500

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical-stage drug development company with a platform technology designed to address multibillion-dollar markets in the treatment of cancer, inflammatory disease and COVID-19. The company's lead drug candidate, Piclidenoson, is currently in Phase III trials for rheumatoid arthritis and psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC) and successfully achieved its primary endpoint in a Phase II trial for treating nonalcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second-line…

TuesdaySep 01, 2020 9:20 am

Aptorum Group Limited (NASDAQ: APM) Starts Presentation at The LD 500

Aptorum Group Limited (NASDAQ: APM) is a biopharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle current unmet medical needs. Aptorum Group is pursuing therapeutic projects in neurology, infectious diseases, gastroenterology, oncology and other disease. The company's current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases. Aptorum Group is also launching a women's health supplement, dioscorea opposita bioactive nutraceutical tablets, marketed under the brand name NativusWell. To date, Aptorum has obtained 11 exclusively licensed technologies in the areas of neurology, infectious diseases, gastroenterology,…

TuesdaySep 01, 2020 9:20 am

Annovis Bio Inc. (NYSE American: ANVS) Starts Presentation at The LD 500

Annovis Bio Inc. (NYSE American: ANVS) is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. With an aging population, neurodegenerative diseases have become one of the world's largest unmet medical needs. Nerve cell death is the underlying cause of all neurodegenerative disease in both slow chronic and fast acute injuries to the brain. Annovis is developing novel treatments that are expected to improve memory loss and dementia associated with Alzheimer's disease and Alzheimer's in Down Syndrome, as well as body and brain function in Parkinson's disease. Annovis has an ongoing…

TuesdaySep 01, 2020 9:00 am

IMAC Holdings Inc. (NASDAQ: IMAC) Starts Presentation at The LD 500

IMAC Holdings Inc. (NASDAQ: IMAC) was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement-restricting diseases and conditions. IMAC owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, multiple Mike Ditka IMAC Regeneration Centers and a Tony Delk IMAC Regeneration Center. IMAC's outpatient medical…